CD74: a new prognostic factor for patients with malignant pleural mesothelioma

BACKGROUND: The pro-inflammatory cytokine migration inhibitory factor (MIF) and its receptor CD74 have been proposed as possible therapeutic targets in several cancers. We studied the expression of MIF and CD74 together with calretinin in specimens of malignant pleural mesothelioma (MPM), correlatin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Otterstrom, C, Soltermann, A, Opitz, I, Felley-Bosco, E, Weder, W, Stahel, R A, Triponez, F, Robert, J H, Serre-Beinier, V
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Molecular Diagnostics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3992494/
https://ncbi.nlm.nih.gov/pubmed/24594996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.117
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires